Pamela P. Pei

Economic Savings Versus Health Losses: The Cost-Effectiveness of Generic Antiretroviral Therapy in the United States

Rochelle P. Walensky, Paul E. Sax, Yoriko Nakamura et al. · Annals of Internal Medicine · 2013 · 128 citations · Full text

Pharmacy, Pharmacoeconomics, Comparative Effectiveness Research +8

The Clinical and Economic Impact of Point-of-Care CD4 Testing in Mozambique and Other Resource-Limited Settings: A Cost-Effectiveness Analysis

Emily P. Hyle, Ilesh Jani, Jonathan Lehe et al. · PLoS Medicine · 2014 · 64 citations · Full text

Public Health, Infectious Disease Control, Pharmacoeconomics +17

Lopinavir/Ritonavir Versus Darunavir Plus Ritonavir for HIV Infection: A Cost-Effectiveness Analysis for the United States

Kit N. Simpson, Pamela P. Pei, Jörgen Möller et al. · PharmacoEconomics · 2013 · 24 citations

Pharmacy, Infectious Diseases, Pharmacoeconomics +12

Development, Calibration and Performance of an HIV Transmission Model Incorporating Natural History and Behavioral Patterns: Application in South Africa

Alethea W. McCormick, Nadia N. Abuelezam, Erin R. Rhode et al. · PLoS ONE · 2014 · 23 citations · Full text

Public Health, Infectious Diseases, Population Health Sciences +15

Cost-effectiveness of a Novel Lipoarabinomannan Test for Tuberculosis in Patients With Human Immunodeficiency Virus

Krishna P. Reddy, Claudia M. Denkinger, Tobias Broger et al. · Clinical Infectious Diseases · 2020 · 19 citations · Full text

Pharmacy, Infectious Diseases, Pharmacoeconomics +16